Some have relabeled it as Pentadecapeptide Aringate or PDA (changing the acetate to an arginate) and therefore are prescribing it for subcutaneous administration that way, although the confusion about its status has led to a lively oral capsule market for BPC in what seems to be a grey space of https://stephenp579eii5.bloggerchest.com/profile